Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1232132.RA1rQmNmVUVITK22BWso1gLuvJtVDXWKCRJIiLaskAgcM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1232132.RA1rQmNmVUVITK22BWso1gLuvJtVDXWKCRJIiLaskAgcM130_assertion type Assertion NP1232132.RA1rQmNmVUVITK22BWso1gLuvJtVDXWKCRJIiLaskAgcM130_head.
- NP1232132.RA1rQmNmVUVITK22BWso1gLuvJtVDXWKCRJIiLaskAgcM130_assertion description "[The purpose of the present study was to investigate the role of sirtuin expression, activity and inhibition in the survival of pediatric sarcoma cell lines.We have analyzed the expression of SIRT1 and SIRT2 in a series of pediatric sarcoma tumor cell lines and normal cells, and we have evaluated the activity of the sirtuin inhibitor and p53 activator tenovin-6 (Tv6) in synovial sarcoma and rhabdomyosarcoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1232132.RA1rQmNmVUVITK22BWso1gLuvJtVDXWKCRJIiLaskAgcM130_provenance.
- NP1232132.RA1rQmNmVUVITK22BWso1gLuvJtVDXWKCRJIiLaskAgcM130_assertion evidence source_evidence_literature NP1232132.RA1rQmNmVUVITK22BWso1gLuvJtVDXWKCRJIiLaskAgcM130_provenance.
- NP1232132.RA1rQmNmVUVITK22BWso1gLuvJtVDXWKCRJIiLaskAgcM130_assertion SIO_000772 25341037 NP1232132.RA1rQmNmVUVITK22BWso1gLuvJtVDXWKCRJIiLaskAgcM130_provenance.
- NP1232132.RA1rQmNmVUVITK22BWso1gLuvJtVDXWKCRJIiLaskAgcM130_assertion wasDerivedFrom befree-2016 NP1232132.RA1rQmNmVUVITK22BWso1gLuvJtVDXWKCRJIiLaskAgcM130_provenance.
- NP1232132.RA1rQmNmVUVITK22BWso1gLuvJtVDXWKCRJIiLaskAgcM130_assertion wasGeneratedBy ECO_0000203 NP1232132.RA1rQmNmVUVITK22BWso1gLuvJtVDXWKCRJIiLaskAgcM130_provenance.